What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non–Small-Cell Lung Cancer
Author:
Affiliation:
1. Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, New York, NY
2. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01446
Reference27 articles.
1. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
2. Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
3. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial
4. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review;Journal of Oncology Pharmacy Practice;2024-06-11
2. (Neo)adjuvant approaches in lung cancer—paving the road to a cure;memo - Magazine of European Medical Oncology;2024-01-19
3. Financial Toxicity in Patients With Resected Lung Cancer;Annals of Surgery;2023-05-30
4. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial;Nature Medicine;2023-03
5. The role of immunotherapy and targeted therapy in the multimodal therapy for resectable lung cancer;Journal of Surgical Oncology;2023-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3